Correlation Between Onconova Therapeutics and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Onconova Therapeutics and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onconova Therapeutics and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Onconova Therapeutics and Coya Therapeutics, Common, you can compare the effects of market volatilities on Onconova Therapeutics and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onconova Therapeutics with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onconova Therapeutics and Coya Therapeutics,.
Diversification Opportunities for Onconova Therapeutics and Coya Therapeutics,
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Onconova and Coya is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Onconova Therapeutics and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Onconova Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onconova Therapeutics are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Onconova Therapeutics i.e., Onconova Therapeutics and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Onconova Therapeutics and Coya Therapeutics,
Given the investment horizon of 90 days Onconova Therapeutics is expected to under-perform the Coya Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Onconova Therapeutics is 1.36 times less risky than Coya Therapeutics,. The stock trades about -0.14 of its potential returns per unit of risk. The Coya Therapeutics, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 487.00 in Coya Therapeutics, Common on September 9, 2024 and sell it today you would earn a total of 125.00 from holding Coya Therapeutics, Common or generate 25.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 6.72% |
Values | Daily Returns |
Onconova Therapeutics vs. Coya Therapeutics, Common
Performance |
Timeline |
Onconova Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Coya Therapeutics, Common |
Onconova Therapeutics and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Onconova Therapeutics and Coya Therapeutics,
The main advantage of trading using opposite Onconova Therapeutics and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onconova Therapeutics position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.Onconova Therapeutics vs. Jaguar Animal Health | Onconova Therapeutics vs. Ibio Inc | Onconova Therapeutics vs. GeoVax Labs | Onconova Therapeutics vs. Ocugen Inc |
Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |